v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 21,864 $ 15,383 $ 40,827 $ 29,051
General and administrative 10,606 6,523 21,242 12,514
Total operating expenses 32,470 21,906 62,069 41,565
Loss from operations (32,470) (21,906) (62,069) (41,565)
Other income:        
Interest income 2,587 3,667 5,407 6,667
Other income (expense), net (3) 171 (3) 348
Total other income 2,584 3,838 5,404 7,015
Net loss $ (29,886) $ (18,068) $ (56,665) $ (34,550)
Net loss per share, basic (in dollars per share) $ (0.66) $ (0.41) $ (1.25) $ (0.98)
Net loss per share, diluted (in dollars per share) $ (0.66) $ (0.41) $ (1.25) $ (0.98)
Weighted-average number of common shares outstanding, basic (in shares) 45,148,971 44,116,997 45,306,105 35,404,928
Weighted-average number of common shares outstanding, diluted (in shares) 45,148,971 44,116,997 45,306,105 35,404,928
Comprehensive loss:        
Net loss $ (29,886) $ (18,068) $ (56,665) $ (34,550)
Unrealized loss on marketable securities (364) (118) (988) (185)
Total other comprehensive loss (364) (118) (988) (185)
Comprehensive loss $ (30,250) $ (18,186) $ (57,653) $ (34,735)